MIMOSA Diagnostics makes MIMOSA Pro, a handheld Class II device using NIRS and multimodal imaging with a cloud workflow to detect early tissue changes and pressure injury risk before visible breakdown. It targets hospitals, clinics, and long‑term care and has regulatory clearance.